Topic List : Cardiovascular Health
Grant to study digital heart-health tools
The award will fund a research program for heart-health technology and a clinical trial for treating hypertension in black and Hispanic participants and in drivers for ride-hailing companies.
AHA chief on research, health equity and more
Robert Harrington, the new president of the American Heart Association, recently discussed his views on technology and diversity in medicine.
Transitional services after heart failure worth cost
A new study asserts that disease-management clinics, home visits by nurses and nurse case management should become the standard of care for elderly patients with heart failure after they are discharged from the hospital.
Nanotherapy reduces artery plaque in mice
Stanford researchers have found that drug-coated nanoparticles limit the development of atherosclerosis in mice, without side effects.
Minimally invasive valve replacement
A recent decision by the Food and Drug Administration opened the door for Sharon Kramer of Atherton, California, to undergo a less-invasive heart valve replacement.
Three elected to National Academy of Medicine
Hongjie Dai, Julie Parsonnet and Joseph Wu are among the 90 regular members and 10 international members elected this year to the academy, which aims to provide independent, scientifically informed analysis and recommendations on health issues.
Invasive heart treatments often needless
A large, international study led by Stanford and New York University found that invasive procedures are no better than medications and lifestyle advice at treating heart disease that's severe but stable.
Through Apple Heart Study, Stanford Medicine researchers show wearable technology can help detect atrial fibrillation
Study shows that Apple Watch app can identify heart rhythm irregularities, which can help catch atrial fibrillation.
Shape-shifting cells protect in artery disease
Stanford scientists and their collaborators have discovered the protective role played by identity-morphing cells — and the gene behind them — in atherosclerosis, according to a new study.
Possible drug target for cardiomyopathy
Stanford researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.